Sign in with Google
|
USD 62.30
Price
1.76
(2.91%)
Day Change
|
|
|---|
HALO, the overall quality is good (Quality = 77) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- OUTPERFORM
- Signal Description
- Company financial health is Good
- Reason
-
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
In details, quality factors are ok , financial health is not good , and ability to make profit is good , ...
| Quality Factors |
|
60% |
| In Recommendations? | In "Invest - Growth" Section |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.10 From 30 days period |
| Social Score | 16 |
| Magic Formula Rank by ROA |
672
|
| Magic Formula Rank by ROE |
672
|
| Magic Formula Rank by ROIC |
792
|
| Price | 62.30 |
| PBV / Sector |
27.24 / 0.60
|
| Earning Per Share | 2.58 |
| PE / Sector |
24.15 / 24.47
|
| PEG or PE/Growth / Sector |
-2.50 / 5.92
|
| Average 1M Daily Value |
75.24 M
|
| Average 1W Daily Value |
58.73 M
|
| Timing Factors |
|
71% |
| Financial Health |
|
41% |
| Ability to Make Profit |
|
77% |
| Return to Investors |
|
12% |
| Registration Details |
| Analyze Date | 2024-09-14 18:48:43 |
| Symbol | HALO |
| Name | HALOZYME THERAPEUTICS INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 126.68 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 7,892.04 / 14,947.33 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
EXEL 
TGTX 
UTHR 
